Transcatheter Pulmonary Valve Replacement clinical trials at UCLA

1 in progress, 0 open to eligible people

Showing trials for

  • ALTERRA: SAPIEN 3 THV With the Alterra Adaptive Prestent

    Sorry, in progress, not accepting new patients

    To demonstrate the safety and effectiveness of the Edwards Alterra Adaptive Prestent in conjunction with the Edwards SAPIEN 3 Transcatheter Heart Valve (THV) System in subjects with a dysfunctional right ventricular outflow tract/pulmonary valve (RVOT/PV) who are indicated for treatment of pulmonary regurgitation (PR). Following completion of enrollment, subjects will be eligible for enrollment in the continued access phase of the trial.

    Los Angeles, California and other locations

Our lead scientists for Transcatheter Pulmonary Valve Replacement research studies include .

Last updated: